02171.HK
CARsgen Therapeutics Holdings Limited
HKSE · Healthcare · Biotechnology · CN
HKD 13.43
+2.36%Margins
Gross margin
61.2%
EBITDA margin
-240.2%
EBIT margin
-282.0%
Net margin
-276.9%
FCF margin
-186.5%
-55.9%
Return on equity
-38.7%
Return on assets
-53.4%
Return on invested capital
0.15x
Asset turnover
-HKD 475.2M
Cash from operations
HKD 2.82
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026